We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APC
1
DELISTED
Anadarko Petroleum
APC
$8.86M 0.7%
111,633
+64,462
+137% +$5.78M
LNKD
2
DELISTED
LinkedIn Corporation
LNKD
$7.84M 0.62%
36,150
+31,093
+615% +$7.08M
CME icon
3
CME Group
CME
$92.2B
$7.65M 0.6%
97,455
+92,372
+1,817% +$7.23M
BBY icon
4
Best Buy
BBY
$18B
$7.44M 0.59%
186,449
+151,431
+432% +$6.21M
C icon
5
Citigroup
C
$222B
$7.28M 0.58%
139,685
+74,989
+116% +$3.8M
PFE icon
6
Pfizer
PFE
$140B
$6.69M 0.53%
+230,320
New +$6.7M
MSFT icon
7
Microsoft
MSFT
$2.84T
$6.24M 0.49%
+166,754
New +$6.06M
TRIP icon
8
TripAdvisor
TRIP
$1.59B
$6.24M 0.49%
75,359
+69,292
+1,142% +$5.67M
MRO
9
DELISTED
Marathon Oil Corporation
MRO
$6.06M 0.48%
171,678
+70,602
+70% +$2.52M
PCYC
10
DELISTED
PHARMACYCLICS INC
PCYC
$5.98M 0.47%
56,515
+50,194
+794% +$6.09M
KR icon
11
Kroger
KR
$34.8B
$5.71M 0.45%
288,682
+230,664
+398% +$4.77M
SIRI icon
12
SiriusXM
SIRI
$10B
$5.5M 0.43%
+157,447
New +$5.88M
BA icon
13
Boeing
BA
$165B
$5.4M 0.43%
+39,534
New +$5.14M
VPHM
14
DELISTED
VIROPHARMA INC
VPHM
$5.33M 0.42%
106,960
+84,461
+375% +$3.78M
WELL icon
15
Welltower
WELL
$178B
$5.33M 0.42%
+99,433
New +$5.91M
JNJ icon
16
Johnson & Johnson
JNJ
$635B
$5.14M 0.41%
56,080
-20,370
-27% -$1.88M
QCOM icon
17
Qualcomm
QCOM
$176B
$5.02M 0.4%
67,623
+61,833
+1,068% +$4.36M
CCI icon
18
Crown Castle
CCI
$32.7B
$4.78M 0.38%
+65,150
New +$4.82M
RSG icon
19
Republic Services
RSG
$66.7B
$4.61M 0.36%
138,842
+120,323
+650% +$4.08M
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
$4.57M 0.36%
79,632
+73,277
+1,153% +$4.26M
TWC
21
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$4.56M 0.36%
33,676
+11,021
+49% +$1.37M
REGN icon
22
Regeneron Pharmaceuticals
REGN
$68.8B
$4.47M 0.35%
+16,252
New +$4.67M
APA icon
23
APA Corp
APA
$12.8B
$4.42M 0.35%
51,466
+22,242
+76% +$1.98M
BIIB icon
24
Biogen
BIIB
$29.9B
$4.24M 0.34%
15,170
+11,225
+285% +$2.9M
COP icon
25
ConocoPhillips
COP
$147B
$4.23M 0.33%
59,845
+54,967
+1,127% +$3.95M
1
2 3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.